Skip to main content
. 2015 Nov 30;17(1):14–19. doi: 10.1080/15384047.2015.1108487

Table 2.

Objective response evaluated by CT scan [n (%)].

  Group A (n = 24) Group B (n = 27) P
Complete response 6 (25.0) 0 (0)  
Partial response 17 (70.8) 13 (48.1)  
Stable disease 0 (0) 9 (37.5)  
Progressive disease 1 (0.42) 5 (18.5)  
Response rate 95.8% 48.1% < 0.001
Disease control rate 95.8% 81.5% 0.053

Group A: hepatic arterial infusion of fluorouracil + capecitabine; Group B: capecitabine alone